Brief: Nurix Therapeutics Announces Board Chair Transition
20/05/2024 21:48
May 20 (Reuters) - Nurix Therapeutics Inc NRIX.O :
* NURIX THERAPEUTICS ANNOUNCES BOARD CHAIR TRANSITION
* NURIX THERAPEUTICS ANNOUNCES BOARD CHAIR TRANSITION
* CURRENT BOARD MEMBER JULIA P. GREGORY UNANIMOUSLY ELECTED
NEW
BOARD CHAIR
* DAVID L. LACEY STEPS DOWN FROM CHAIR ROLE AND WILL REMAIN
BOARD
MEMBER AND RETAIN COMMITTEE LEADERSHIP ROLES
Source text for Eikon: ID:nGNX9f0Q88
Further company coverage: NRIX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Nurix Therapeutics
See all newsNurix Therapeutics Q3 swings to profit on Roche collaboration
Brief: Nurix Extends Gilead Collaboration For Oncology Program
Commercialize Potential Best-In-Class Btk Degrader Bexobrutideg Across Malignant Hematology, Immunology And Neurology
Nurix Therapeutics Q2 revenue falls sharply, net loss widens; strikes up to $2.3 bln collab with Roche
U.S. RESEARCH ROUNDUP- Datadog, Jabil, Prologis